Compare Immunovant Inc. Common Stock (IMVT) vs iShares Semiconductor ETF (SOXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs iShares Semiconductor ETF — how do they compare? Immunovant Inc. Common Stock trades at $30.27 (market cap $6.25B), while iShares Semiconductor ETF trades at $561.82 (market cap $48.19B). The key difference: iShares Semiconductor ETF is far larger — about 7.7× Immunovant Inc. Common Stock's market cap, and iShares Semiconductor ETF is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and iShares Semiconductor ETF for 46 Days on average.
| IMVT | SOXX | |
|---|---|---|
Market Cap | $6.25B | $48.19B |
Volume | 1,755,411 | 10,257,578 |
Sector | Health | Sector/Thematic |
52-Week High | $44.96 | $655.01 |
52-Week Low | $17.03 | $268.10 |
Typical Hold Time | 0 Days | 46 Days |
Enterprise Value | $5.35B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXX trades at $582.94, down 1.1% today but maintains a bullish technical stance with strong moving average support. The semiconductor ETF benefits from AI-driven demand, with recent news highlighting sector gains and positive earnings momentum. However, high valuations and Michael Burry's expanded short position signal caution amid the AI boom.
Outlook remains positive due to structural AI growth, but risks include valuation concerns and sector concentration. Earnings growth supports further upside, though macroeconomic conditions and competitive pressures could temper returns. Investors should balance optimism with prudent risk management.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About iShares Semiconductor ETF
SOXX provides investors with exposure to U.S. companies that design, manufacture, and distribute semiconductors. It tracks the ICE Semiconductor Index, offering a targeted investment in the technology sector's foundational components, including firms that produce chips, related equipment, and services. SOXX is a key vehicle for investors seeking to capitalize on trends in artificial intelligence, 5G, and other technologies that rely heavily on advanced semiconductor technology.
Read more on SOXX →
